SecBot SecBot
144 ·Filed Nov 3, 2026

CHE

CHEMED CORP
NEUTRAL
Impact 2/10
Horizondays Processed13d 10h ago SEC0001628280-26-069375
Form 144: notice of proposed sale of securities
Actionable Insight • Neutral

The insider has been selling a consistent 2,000-share block each month since August 2026, suggesting a pre-arranged 10b5-1 plan or routine portfolio diversification. No material change in company outlook is signaled by this filing alone.

DirectionNeutral
Confidencehigh
Horizondays

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5
Entry
$533.65
T+0 close · Nov 3, 2026 · via day close
Latest settled
+2.03%
T+5 · $544.49 · next T+20 in 15d
Vs SPY
+2.62%
α at T+5
Latest observation
+2.74%
T+9 · FF3 residual α
  1. T+0 · Nov 3 $533.65entry
  2. T+1 · 13d ago +2.81%α +1.16% · $548.64
  3. T+5 · 7d ago +2.03%α +2.62% · $544.49
  4. T+9 · todayOpen
  5. T+20 · in 15d Pending
  6. T+60 · in 3mo Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Kevin J. McNamara, an officer/director of Chemed Corp, filed a Form 144 notice of intent to sell 2,000 shares of common stock, with an estimated aggregate market value of approximately $1.08 million based on a recent price of $542.18. The shares were acquired through stock awards and exercises in 2023 and 2025. This is a routine insider sale notice and represents a small fraction of the insider's total holdings and the company's $7.1B market cap.

Key Facts

  • Kevin J. McNamara, an officer/director, filed Form 144 on 2026-11-03.
  • Proposed sale of 2,000 shares of Chemed Corp common stock.
  • Estimated aggregate market value of the sale is approximately $1.08 million (2,000 shares at ~$542.18 per share).
  • Shares were acquired through stock awards and exercises on 05/05/2025 (1,018 shares), 02/14/2025 (679 shares), and 05/02/2023 (303 shares).
  • The sale is planned for execution on or after 11/03/2026 on the NYSE.
  • The insider has sold shares in three recent transactions (08/21/2026, 09/17/2026, 09/28/2026), each for 2,000 shares at prices around $541-$513.
  • The proposed sale represents less than 0.02% of Chemed's $7.1B market cap.

Financial Impact

Proposed sale of 2,000 shares valued at ~$1.08M, less than 0.02% of market cap.

dilution

Risk Factors

  • Form 144 is an intent to sell; the sale may not occur.
  • Insider selling could be misinterpreted as a negative signal, but the pattern appears routine.

Market Snapshot

Exchange
NYSE
Sector
Services-Home Health Care Services
Analyst Consensus
67% bullish (9 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001628280-26-069375
Document: 0001628280-26-069375-index.html0001628280-26-069375
Document: 0001628280-26-069375.txt0001628280-26-069375

Track record

19 reports on CHE

Performance horizon

2 of 3 bullish or bearish reports moved the stock their way by T+5. Best: +2.86% at T+5 after the Oct 27, 2026 report. 3 of 3 went positive at some point.

Filters
  1. Nov 6, 202610d ago Press Release Neutral 2/10 Entry $528.05 to $548.20 Now $549.45 +4.05% ▲ +3.82% +1.22% vs SPY
  2. Nov 5, 202611d ago Insider Cluster Bearish 4/10 Entry $533.77 to $550.20 Now $549.45 −2.94% ▼ −3.08% +0.21% vs SPY
  3. Nov 3, 202613d ago 144 Neutral 2/10 Viewing Entry $533.65 to $544.49 Now $549.45 +2.96% ▲ +2.03% +2.62% vs SPY
  4. Oct 27, 202620d ago Institutional Cluster Mixed 4/10 Entry $533.36 to $548.64 Now $549.45 +3.02% ▲ +2.86% +3.58% vs SPY
  5. Oct 27, 202620d ago 8-K Bullish 6/10 No price data
  6. Oct 27, 202620d ago Press Release Bullish 6/10 Entry $533.36 to $548.64 Now $549.45 +3.02% ▲ +2.86% +3.58% vs SPY
  7. Oct 23, 202624d ago Institutional Cluster Mixed 3/10 Entry $512.98 to $534.72 Now $549.45 +7.11% ▲ +4.24% +4.80% vs SPY
  8. Oct 1, 20266w ago Press Release Neutral 1/10 Entry $502.90 to $498.25 Now $549.45 +9.26% ▼ −0.92% −2.23% vs SPY
  9. Sep 16, 20268w ago Press Release Neutral 4/10 Entry $505.97 to $495.65 Now $549.45 +8.59% ▼ −2.04% −2.64% vs SPY
  10. Aug 24, 202612w ago Insider Cluster Neutral 3/10 Entry $541.34 to $518.71 Now $549.45 +1.50% ▼ −4.18% −4.65% vs SPY
Showing 10 of 19

US Market Status

Market Closed · Opens in 8h 19m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 3, 2026